title: Comparison of three high affinity SPECT radiotracers for the dopamine D2 receptor.
abstract: The regional brain distribution and pharmacological specificity of three high affinity tracers for the dopamine (DA) D2 receptor: [123I]IBF, [123I]epidepride, and [123I]2'-ISP were assessed by SPECT imaging of non-human primates. The ratios of striatal-to-occipital activities at the time of peak striatal uptake were 2.2, 6.3 and 1.7, respectively. From the peak striatal activities, washout rates were 33, 4 and 16%/h for [123I]IBF, [123I]epidepride and [123I]2'-ISP, respectively. The reversibility of the striatal uptake of all three agents was demonstrated by the rapid displacement induced by the dopamine D2 selective antipsychotic agent raclopride, which increased washout rates to 96, 58 and 43%/h. The administration of d-amphetamine, which induces release of dopamine, had no noticeable effect on [123I]epidepride but increased the washout rate of [123I]IBF. These results suggest that, among these three agents, [123I]epidepride is the superior tracer for in vivo displacement studies because of its slow washout and high target-to-background ratios. However, for tracer kinetic modeling, [123I]IBF may be the superior agent because of its early time of peak uptake and its higher target-to-background ratios than [123I]2'-ISP.
authors.affiliation: Department of Psychiatry, Yale University/VA Medical Center, West Haven, CT 06516, USA.
authors.forename: M S
authors.initials: MS
authors.lastname: al-Tikriti
authors.forename: R M
authors.initials: RM
authors.lastname: Baldwin
authors.forename: Y
authors.initials: Y
authors.lastname: Zea-Ponce
authors.forename: E
authors.initials: E
authors.lastname: Sybirska
authors.forename: S S
authors.initials: SS
authors.lastname: Zoghbi
authors.forename: M
authors.initials: M
authors.lastname: Laruelle
authors.forename: R T
authors.initials: RT
authors.lastname: Malison
authors.forename: H F
authors.initials: HF
authors.lastname: Kung
authors.forename: R M
authors.initials: RM
authors.lastname: Kessler
authors.forename: D S
authors.initials: DS
authors.lastname: Charney
mesh_terms: D000818:Animals; D001549:Benzamides / Q000378:metabolism; D001572:Benzofurans / Q000378:metabolism; D001921:Brain / Q000378:metabolism*; D003287:Contrast Media; D003913:Dextroamphetamine / Q000494:pharmacology; D015259:Dopamine Agents / Q000494:pharmacology; D005260:Female; D007457:Iodine Radioisotopes; D010215:Papio; D011759:Pyrrolidines / Q000378:metabolism; D020891:Raclopride; D017448:Receptors, Dopamine D2 / Q000378:metabolism*; D016713:Ritanserin / Q000494:pharmacology; D012457:Salicylamides / Q000494:pharmacology; D012702:Serotonin Antagonists / Q000494:pharmacology; D013134:Spiperone / Q000031:analogs & derivatives; D014018:Tissue Distribution / Q000502:physiology; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: D001549:Benzamides; D001572:Benzofurans; D003287:Contrast Media; D015259:Dopamine Agents; D007457:Iodine Radioisotopes; D011759:Pyrrolidines; D017448:Receptors, Dopamine D2; D012457:Salicylamides; D012702:Serotonin Antagonists; C053751:2'-iodospiperone; C063525:epidepride; D016713:Ritanserin; D020891:Raclopride; D013134:Spiperone; D003913:Dextroamphetamine